Tissue-specific and age-dependent effects of global Mdm2 loss

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Mdm2 is an E3 ubiquitin ligase that negatively regulates the tumor suppressor p53.
• Understanding Mdm2's role is crucial for developing targeted cancer therapies.

Purpose of the Study:

• To investigate the effects of global Mdm2 loss in adult mice using a conditional Mdm2 allele and a tamoxifen-inducible recombination system.
• To determine the impact of Mdm2 loss on various tissues and its dependence on p53.

Main Methods:

• Utilized a conditional Mdm2 allele (Mdm2(FM)) and a CAG-CreER tamoxifen-inducible system in adult mice.
• Administered two different tamoxifen injection regimens to induce global Mdm2 loss.
• Analyzed tissue pathology, transcriptional activation of key genes (Cdkn1a, Bbc3), and senescence markers in young and aged mice.
• Compared phenotypes in p53-wild-type and p53-null (Trp53(-/-)) mice.

Main Results:

• Global Mdm2 loss led to 100% lethality in Mdm2(FM)(/-);CAG-CreER mice, with impairment in both radio-sensitive and radio-insensitive tissues.
• Radio-insensitive tissues (kidney, liver, heart, retina, hippocampus) showed pathological defects in young mice.
• Older mice (16-18 months) primarily exhibited kidney abnormalities.
• Transcriptional activation of Cdkn1a, Bbc3, and senescence markers was dampened in older mice.
• All observed phenotypes were p53-dependent, as Mdm2(FM)(/-);Trp53(-/-);CAG-CreER mice remained normal.

Conclusions:

• Global Mdm2 loss induces significant toxicities across multiple normal tissues in adult mice.
• Age influences the severity and tissue specificity of Mdm2 loss-induced phenotypes.
• The findings suggest potential toxicities associated with Mdm2-inhibiting cancer therapies in tumors with wild-type p53.